Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPP635 in Mild to Moderate Hypertension
NCT00376636Phase 2Completed
- Sponsor
- Speedel
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing SPP635 Arm with Placebo Arm (2 arms). Primary endpoints: Systolic Blood Pressure at 4 weeks and Diastolic Blood Pressure at 4 weeks. Started Oct 2006; status: completed.
02
Drugs
SPP 635
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00376636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376636.